Cardio- and Cerebrovascular Risk With Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) in Rheumatoid Arthritis (RA): a Real-World Comparative Assessment

Jun-20

Cardiovascular Neurology Pharmacoepidemiology

AUTHORS : Dr Albert Prats-Uribe, NDORMS, University of Oxford, Botnar Research Centre, Windmill Road , Oxford OX3 7LD , UK – Email: albert.prats-uribe@ndorms.ox.ac.uk – Profile: https://www.ndorms.ox.ac.uk/team/albert-prats-uribe

JOURNAL : Annals of the Rheumatic Diseases

REFERENCE: 79(S1):1002

DOI : 10.1136/annrheumdis-2020-eular.3463

Read more

More publications

Mar-25

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Neurology

Read more

Jan-25

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Pharmacoepidemiology

Read more

Jan-25

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Pharmacoepidemiology

Read more